<DOC>
	<DOCNO>NCT01246765</DOCNO>
	<brief_summary>The purpose National Pregnancy Registry Atypical Antipsychotics determine frequency birth defect among infant expose atypical antipsychotic .</brief_summary>
	<brief_title>National Pregnancy Registry Atypical Antipsychotics</brief_title>
	<detailed_description>The National Pregnancy Registry Atypical Antipsychotics dedicate evaluate safety atypical antipsychotic medication may take woman pregnancy treat wide range mood , anxiety , psychiatric disorder . The primary goal Registry determine frequency major malformation , heart defect , cleft lip , neural tube defect , infant expose atypical antipsychotic pregnancy . We currently study follow medication : - Abilify ( aripiprazole ) - Aristada ( aripiprazole lauroxil ) - Clozaril ( clozapine ) - Fanapt ( iloperidone ) - Geodon ( ziprasidone ) - Invega ( paliperidone ) - Latuda ( lurasidone ) - Rexulti ( brexpiprazole ) - Risperdal ( risperidone ) - Saphris ( asenapine ) - Seroquel ( quetiapine ) - Zyprexa ( olanzapine )</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Pregnant woman Age 1845 Currently take take atypical antipsychotic pregnancy ( internal control , woman expose atypical antipsychotic ) Subjects willing participate phone Subjects able provide inform consent Women complete pregnancy Women plan become pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Atypical Antipsychotics pregnancy</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Medication use pregnancy</keyword>
</DOC>